- Home
- PRZO vs DYAI Comparison
PRZO vs DYAI Comparison
Compare PRZO & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRZO
- DYAI
- Stock Information
- Founded
- PRZO 2014
- DYAI 1979
- Country
- PRZO Israel
- DYAI United States
- Employees
- PRZO N/A
- DYAI N/A
- Industry
- PRZO
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRZO
- DYAI Health Care
- Exchange
- PRZO Nasdaq
- DYAI Nasdaq
- Market Cap
- PRZO 32.3M
- DYAI 30.2M
- IPO Year
- PRZO 2023
- DYAI 2004
- Fundamental
- Price
- PRZO $1.59
- DYAI $1.15
- Analyst Decision
- PRZO
- DYAI Strong Buy
- Analyst Count
- PRZO 0
- DYAI 2
- Target Price
- PRZO N/A
- DYAI $4.50
- AVG Volume (30 Days)
- PRZO 1.3M
- DYAI 108.3K
- Earning Date
- PRZO 08-28-2025
- DYAI 11-11-2025
- Dividend Yield
- PRZO N/A
- DYAI N/A
- EPS Growth
- PRZO N/A
- DYAI N/A
- EPS
- PRZO N/A
- DYAI N/A
- Revenue
- PRZO $1,007,440.00
- DYAI $4,135,078.00
- Revenue This Year
- PRZO N/A
- DYAI $34.23
- Revenue Next Year
- PRZO N/A
- DYAI $19.57
- P/E Ratio
- PRZO N/A
- DYAI N/A
- Revenue Growth
- PRZO 80.42
- DYAI 129.20
- 52 Week Low
- PRZO $0.53
- DYAI $0.71
- 52 Week High
- PRZO $3.16
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- PRZO 50.49
- DYAI 55.51
- Support Level
- PRZO $1.35
- DYAI $1.02
- Resistance Level
- PRZO $1.59
- DYAI $1.17
- Average True Range (ATR)
- PRZO 0.13
- DYAI 0.09
- MACD
- PRZO -0.02
- DYAI -0.00
- Stochastic Oscillator
- PRZO 45.63
- DYAI 53.93
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the company applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.